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CBA/HN (CN)' mice are asubline ofCBA mice with a marked defect in antibody-forming
ability . Initially, it was shown that they failed to form specific antibody in response to
immunization with type III pneumococcal polysaccharide (SIII) and bacterial lipopolysac-
charide (LPS) (1) . Subsequent studies of these animals have shown that they did not
make adetectable antibody response to polyinosinic-polycytidylic acid (poly I - C) (2) or to
the 2,4-dinitrophenyl-lysyl derivative of Ficoll (DNP-lys-Ficoll) . 2 All of these antigens
evoke vigorous antibody responses in all other mouse strains studied, even if these mice
are deprived of thymus-dependent (T) lymphocytes (3-6) . Thus, these antigens have been
referred to as "T-independent" antigens . The response of CN mice to T-dependent
antigens such as sheep red blood cells (SRBC) has been less well studied, but they have
been shown to make easily detectable, although less than normal, responses to SRBC (1)
and to other T-dependent antigens .' In addition, the levels of circulatingIgM in theCN
mice were shown to be very low (7) . These data all suggest a defect in theT-independent
antibody-forming system ofCN mice (2) .
Genetic studies of the immune response to SIII and poly I - C in the CN mice
demonstrated that their inability to respond to these antigens was inherited as an
X-linked recessive trait (1, 2) . Thus, when CN females are crossed to normal male mice,
* This work was supported in part by the Bureau of Medicine and Surgery Work Unit nos .
MR041.02.01 .0020B2G I and CICC 3-06-132 . The opinions or assertions contained herein are the
private ones of the authors and are not to be construed as official or reflecting the views of the Navy
Department or the naval service at large . The animals used in this study were handled in accordance
with the provisions of Public Law89-54 as amended by Public Law 91-579, the "Animal Welfare Act
of 1970" and the principles outlined in the "Guide for the Care and Use of Laboratory Animals," U.S .
Department of Health, Education and Welfare publication no . (NIH) 73-23 .
'Abbreviations used in this paper : ADCC, antibody-dependent cell cytotoxicity ; CJ, CBA/J; CN,
CBA/HN ; Con-A, concanavalin A; C6, C57BL/6 ; DN, DBA/2N ; DNP-lys-Ficoll, 2,4-dinitrophenyl-
lysyl-derivative of Ficoll ; FCS, fetal calf' serum ; ['H]TdR, [methyl- 3H]thymidine ; KLH, keyhole
limpet hemocyanin ; LPS, bacterial lipopolysaccharide ; MBLA, mouseB-lymphocyte antigen ; NMS,
normal mouse serum; NRS, normal rabbit serum ; PHA, phytohemagglutinin ; poly I -C, polyinosinic-
polycytidylic acid ; SIII, pneumococcal polysaccharide .
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the F, male progeny are unable to form antibody to SIII and poly I -C whereas the F,
female progeny forms normal amounts of antibody .
CN mice provide an excellent system in which to evaluate the X-linked genetic
control of immune responsiveness and may provide an important model for the
study of the ontogeny, differentiation, and activation of bone marrow-derived (B)
lymphocytes. In this communication, we present studies demonstrating that the
numbers ofB lymphocytes in the spleens of CN mice and of F, male progeny of
crosses of CN females with DBA/2N (DN) male mice (CN x DN F, males) are
diminished . In addition, we show that the response of lymphocytes of CN mice
and CN x DN F, male mice to agents mitogenic for T-independent lymphocytes
(B mitogens) is impaired and that they also have an impaired ability to
participate in antibody-dependent cell-mediated cytotoxicity (ADCC) . On the
other hand, these mice display relatively normal T-lymphocyte function as
judged by mitogen responses to concanavalin-A (Con-A) and phytohemagglu-
tinin-P (PHA), by specific in vitro T-lymphocyte-mediated cytotoxicity and by
skin graft rejection .
Materials and Methods
Animals.
￿
CN, DN, and C57BL/6 (C6) mice as well as F, and backcross animals derived from
these strainswere obtained from the Rodent andRabbit Production Section of the National Institutes
of Health, Bethesda, Md . CBA/J (CJ) mice were purchased from Jackson Laboratories, BarHarbor,
Maine. All mice were 6-12 wk of age at the time of their study . TheCN mice are a distinct subline of
CBA mice, and the history of their establishment has been described in detail elsewhere (1, 2) . F,
animals derivedfrom the CN strain were produced by breeding a CN female with aDN male and are
referred to as CN x DN F, males or females .
Cell Suspensions . Mice were killed by cervical dislocation and their spleens removed using
aseptic technique . Spleen cells were obtained by gentle teasing with a rubber policeman into RPMI
1640 medium (Grand Island Biological Co ., Grand Island, N . Y .) . Cell aggregates were disrupted by
passing the cell suspension through a 26-gauge needle . The single cell suspensions were then washed
twice with RPMI 1640 . Cell counts were determined with a Fisher Autocytometer (Fisher Scientific
Co ., Silver Spring, Md .) .
Antisera .
￿
Rabbit antimouse B-lymphocyte antisera (anti-MBLA) was prepared according to the
method of Raff et al . (8) . AKR anti-Thy . 1.2 (anti-0) was prepared by the method of Reif and Allen
(9) . Rabbit antimouse a-serum was a gift of Dr . R. Mage, National Institute of Allergy andInfectious
Diseases, NIH, Bethesda, Md . ; it was purified by absorption to and elution from an agarose affinity
column to which mouse K-type myeloma proteins of the y,- and y,-classes had been coupled . Mouse
anti-Ia.8 antiserum was prepared by immunizing B10.A mice with lymphocytes from B10 mice (10)
and was the gift of Dr . D. Sachs, National Cancer Institute, NIH, Bethesda, Md. This antisera
recognizes an Ia antigen present in H-2° mice and expressed principally on B lymphocytes . All
antisera were inactivated for 30 min at 56°C before use.
Immunofluorescence andAutoradiography .
￿
5 million spleen cells were treated with Tris-buffered
ammonium chloride, according to the method of Boyle (11), in order to remove redblood cells(RBC) ;
they were then resuspended in 100 Pl ofRPMI 1640 with 10% fetal calfserum (FCS) (GIBCO) and 1%
sodium azide (Calbiochem, San Diego, Calif.) . This suspension was incubated at 4°C for 30 min with
50 11 of fluorescein-labeled rabbit anti-a (prepared as previously described) (12) . After incubation, the
cellswere recovered by centrifugation, washed threetimes in 5 ml ofRPMI 1640, andexamined in the
living state with a fluorescence microscope equipped with an incident light ultraviolet illuminator .
Small round cells were located by using a tungsten light source, and fluorescence of such cells was
evaluated after switching to an ultraviolet source .
Autoradiography was performed as previously described (13), by adding 0.125 JAg (10 Ail) of
"II-labeled anti-)c antibody (25-35 yCi/Ag ; radioiodinated by the chloramine-T method) to a790 X-LINKED B-LYMPHOCYTE DEFECT
suspension of 5 x 10 6 spleen cells (in 100 yl of RPMI 1640, 10% FCS, and 1% sodium azide) . This
suspension was incubated at 4°C for 30 min andthen washed three timesby pelleting cells through5
ml of FCS . The cell pellet was smeared on glass slides which were then fixed in glutaraldehyde,
washed, and dipped in nuclear tract emulsion (NTB-2, Eastman Kodak Co ., Rochester, N. Y.) .
Autoradiographs were exposed for 2-10 days . These cells were stained with methyl-green pyronin ;
small round nonpyroninophilic cells were scored for grains .
Complement (C)-Dependent Cytotoxicity .
￿
Spleen cells fromCN x DN F, males or females were
labeled with "Cr in order to assay the relative ability of anti-B, anti-MBLA, anti-Ia.8, and anti-u to kill
these cells . 10 million spleen cells, treated to remove RBC, were suspended in 0.5 ml of 10% FCS in
RPMI 1640 to which wasadded0.2 mCi of sodium "Cr (1 mCi/ul, Amersham/Searle Corp ., Arlington
Heights, 111 .) . The mixture was incubated for 30 min at 37°C . The cells were washed three times in 20
vol of RPMI 1640 and brought to 1 x 10 6 cells/ml . 50 gl of this suspension was incubated in triplicate
with 50 ul of various dilutions of antisera at room temperature for 15 min . Rabbit serum (50 Ail of a 1:4
dilution) was added as a source of C and the mixture incubated for an additional 30 min at 37°C .
After sedimentation of the cells by centrifugation at 200 g for 10 min, 100 ul of the supernatant fluid
was removed and the radioactivity measured in a gamma ray spectrometer. Total releasable
radioactivity was determined by freeze-thawing samples containing labeled cells and medium .
Controlsamples contained labeled cells, normal mouseserum (NMS) or normal rabbit serum (NRS),
and C . The percent lysis was determined by the following formula :
radioactivity released by antisera and C -
radioactivity released byNMS (NRS)and C
% Net chromium released =
￿
x 100 .
radioactivity released by freeze-thawing -
radioactivity released byNMS (NRS)and C
All lots of C were absorbed with 0.1 vol of mouse liver powder (Miles Laboratories, Inc ., Miles
Research Div., Kankakee, Ill .) for 1 h at 4°C .
Stimulation by Mitogenic Agents .
￿
The mitogens employed in these studies were used at levels
determined by preliminary experiments to give optimum stimulation with DN spleen cells . RPMI
1640 with N-2-hydroxyethyl-piperazine-N'-2-ethane sulf'onic acid buffer (25 mM ; Calbiochem),
penicillin (100 U/ml), streptomycin (100,ug/ml), and L-glutamine (2 mM) was used as medium for the
mitogen experiments . PHA-P(Difco Laboratories, Detroit, Mich .) wasused at 0.1% ; LPS Escherichia
coli 0111:134 (Difco Laboratories) was used at 50 ug/ml ; poly I - C (P-L Biochemicals Inc., Milwaukee,
Wis.) was used at 250 gg/ml ; and Con-A (Calbiochem) was used at 1.25 ug/ml .
Cultures were established in sterile tissue culture microtiter plates (no . 3040, Falcon Plastics,
Division of BioQuest, Oxnard, Calif'.) . 100 MI of 6 x 10 6 spleen cells/ml in medium (6 x 10 5
cells/culture) and 50 ul of medium containing the mitogen were added . In some experiments, FCS
was added to yield a 10% solution and in certain other experiments, thenumber ofcells added to each
culture was varied from 2 x 10 5 to 1 x 10 6 . These cultures were covered with sterile raised lids
(Limbro no . 55, Bellco Glass, Inc ., Vineland,N. J.) and cultured for 72 h, unless otherwise noted, in a
humidified atmosphere of 95% air, 5% CO 2 at 37°C . 18 h before harvesting, 20 ul ofmediacontaining 1
uCi of [methyl-'H]thymidine (['H]TdR) 1.9 Ci/mM (Schwarz/Mann Div., Becton, Dickinson & Co .,
Orangeburg, N. Y.) was added to each well . Cultures were harvested using the multiple automated
sample harvester (14), transferred to 1-dram vials, and 3 ml of Liquiflor (New England Nuclear,
Boston, Mass .), were added .Thesamples were counted in a liquid scintillation spectrometer and data,
counts per minute, are reported as the mean of triplicate cultures, plus or minus the standard error
(tSE), unless otherwise indicated .
Skin Grafting .
￿
Skin grafts from C6 mice to CN xDN F, males andfemales were made according
to the technique of Billingham and Medawar (15) . The casts were removed after8days andthe site of
transplantation was macroscopically examined daily for signs of rejection . The data are expressed as
the time required for rejection . Statistical analysis of the data was analyzed using the rank sum
method .
Lymphocyte-Mediated Cytotoxicity .
￿
21 days after receiving C6 skin grafts CN x DN F, males
and females were given 50 x 10 6 C6 spleen cells by intraperitoneal injection. 10 days later, they were
bled from the retro-orbital sinus and sacrificed . Spleen cells from these animals were treated toSCHER, AHMED, STRONG, STEINBERG, AND PAUL
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remove RBC andsuspended in RPMI 1640 with 10%FCSat 6 x 108 cells/ml . 100 Al ofthese cells were
added to amicrotiter well in triplicate along with 100 ul ofwashed EL-4 tumor cells at 6 x 10' cells/ml
which had been labeled with sodium "C as noted previously. This mixture was allowed to incubate
under 95% air, 5% C02 at 37°C for 16 h; 100 P1 of the supernatant fluid was collected after
centrifugation at 200 g for 10 min and assayed for radioactivity. The percent lysis was calculated as
noted previously.
ADCC.
￿
6 x 10' "Cr-labeled EL-4 tumor cells in I ml ofRPMI 1640 were incubated for 1 hat 37 1C
with 0.25 ml of antiserum produced by the CN x DN F, mice described in the previous section. The
cells were washed in 4 vol of RPMI 1640 and resuspended in 1 ml of RPMI 1640. 100 Al of these
sensitized labeled cells were added to microtiter wells. In addition, 100 Al of a suspension of spleen
cells from unsensitized mice of various strains, in RPMI 1640 medium with 10% FCS at 6 x 108
cells/ml, were added to each well in triplicate. The cells were incubated for 4h in the same manner as
in the lymphocyte-mediated cytotoxicity experiments. After centrifugation at 200gfor 10 min, 100 Al
of the supernatant fluid wascollected and assayed for radioactivity. Thepercent lysis wascalculated
as noted previously .
Treatment of Spleen Cell to Enrich for BLymphocytes.
￿
Spleen cells obtained from either CN x
DN F, males or females were depleted of adherent cells and T lymphocytes by the following
techniques. The spleen cells were suspended in RPMI 1640 (5% FCS) at 25 x 108 cells/ml and
incubated at 37'C for 60 min in 100-mm plastic culture dishes (Falcon Plastics, Div. of BioQuest) .
The nonadherent cells that were recovered after two 60-min incubations were then treated with
anti-B sera and C anddead cells were removedby Ficoll-Hypaque density centrifugation as described
in a previous report (16).
Results
Numbers of Nucleated Cells per Spleen in C6 x DN F, , CJ, CN x DN F, ,
and CN Mice. The number of nucleated cells per spleen of CJ, CN, CN x DN,
and C6 x DN males and females is shown in Fig. 1. These data were gathered
over a period of 6 mo on animals which were between 6 and 10 wk of age. The CN
male and female mice have approximately 60 x 106 nucleated cells/spleen vs. the
CJ inbred strain or the C6 x DN F, mice which have approximately 120 x 106
nucleated cells/spleen. There is little difference between the numbers of
nucleated spleen cells in the males or females of the C6 x DN F, mice. However,
the numbers of spleen cells in the CN x DN F, females is significantly greater
than in the F, males (92 x 106 zE 5.0 vs . 51 x 10 6 =i: 4.1, P< 0.001). Thus, the CN
x DN F, females have considerably more nucleated cells per spleen than their F,
male littermates although somewhat fewer than a similar F, strain or the CJ
strain. The CN males and females resemble the CN x DN F, males in the
numbers of nucleated cells per spleen .
Percentage of Kappa-Bearing Cells per Spleen.
￿
Spleen cells from male and
female CN, DN, and CN x DN F, mice were treated with anti-a which had been
labeled with either fluorescein or "'I. Approximately 50% of both male and
female DN spleen cells were labeled as is shown in Fig. 2. There was no statisti-
cal difference between the males and females in the DN mice or the CN mice.
However, the CN mice had only approximately 22% positive cells. The CN x DN
F, males had a mean of 26% «-bearing spleen cells and thus resembled the CN
mice whereas the CN x DN F, females had an intermediate value with a mean of
39.9%, a highly significant difference (P < 0.005) from that of the F, males.
Percent Chromium Released by Antisera-Treated Spleen Cells. Fig. 3 a
shows the percent net chromium released by CN x DN male and female cells
treated with anti-B and C. There was little difference in the chromium released792
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￿
Number of nucleated cells in thespleens of C6 x DN F, malesandfemales, CN xDN
F, males and females, CN males andfemales, and CJ males . Each point represents data from
an individual animal and the mean of each group is shown by the horizontal dashed line .
from male or female cells treated in this manner . When anti-IC (Fig . 3 b), anti-la.8
(Fig . 3 c), or anti-MBLA (Fig . 3 d) and C were used to treat CN x DN F, spleen
cells, considerable differences in the net chromium released were noted between
the male and female cells . At the highest concentration of antisera used, the
amount of chromium released by the F, male cells was approximately 1/3 of the
chromium released by the F, female cells (0.34, 0.27, and 0.32 for the anti -K,
anti-la.8, and anti-MBLA, respectively) .
Response of Spleen Cells to Nonspecific Mitogens . Individually cultured
spleen cells from male and female CN, CN x DN, and C6 x DN mice which were
incubated for 3 days in the absence of mitogens and FCS incorporated little
[3H]TdR as is shown in Fig. 4 . However, there was significantly more incorpora-
tion by the unstimulated CN x DN F, female cells than the unstimulated F,
male cells (P < 0.001) . The ['H]TdR incorporated by unstimulated F, male
spleen cells was similar to that of cells from CN mice whereas the incorporation of
[3H]TdR by F, female spleen cells was similar to C6 x DN cells . The T-cellZ 20
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￿
Percent positive small round cells stained with fluorescein-labeled (") or "II-labeled
(O) rabbit antimouse-K, in spleen cell suspensions from male and female CN,CN x DN, and
DN mice . Each point represents data from an individual animal and the mean ofeach group is
shown by the horizontal dashed line .
mitogens PHA and Con-A induced an excellent response in the absence ofFCS in
spleen cells from both male and female mice of all strains studied (Fig . 4) .
However, the response of the spleen cells from CN males and females and CN x
DN F, males, under similar conditions, to the B-cell mitogens LPS and poly I -C
was quite low (<4,000 cpm and <3,500 cpm, respectively) . This low response
persisted in the spleen cells of these animals when they were stimulated with a
concentration of LPS from 25 to 50 ug/ml or poly I -C from 50 to 250beg/ml in the
presence of 10% FCS (Fig . 5) . When CN x DN F, females and C6 x DN males
or females were stimulated with LPS or poly I - C, an excellent response was
seen in the absence (Fig . 4) or presence (Fig . 5) of 10% FCS. The response of
spleen cells from a pool of four CN x DN F, males and four F, femalesto poly I -C
(250 Ng/ml) in 10% FCS at 24, 48, 72, and 96 h is shown in Fig . 6. Although the
maximum response to poly I .C of cells from F, males occurred slightly later than
that of F, female cells, at no time did the response of the F, male cells approach
that of the F, female cells .
In order to determine the influence of increasing the number of spleen cells per
culture on the response seen with LPS or poly I-C, experiments were run with
from 2 x 105 to 8 x 10 5 spleen cells/culture in the presence of 5% FCS (Fig . 7) .
The response induced by these B-cell mitogens on both CN x DN F, male and794
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￿
Percent "Cr released from spleen cells from CN x DN F, males ("-" ) or females
(O---O) treatedwith (a) anti-B, (b) anti-K, (c) anti-Ia.8, or (d) anti-MBLAand C.
female spleen cells increased as the-number of cells per culture was increased.
However, the response of 8 x 10 5 male cells was significantly lower than the
response of 4 x 10 5 female cells to both LPS and poly I .C . In a similar
experiment, varying numbers of spleen cells depleted of both adherent cells and
T lymphocytes were cultured in the presence of LPS or poly I-C (Fig . 8) . The
response to LPS of 1 x 10 6 male cells was similar to 4 x 10 5 female cells and the
response to poly I -C of 1 x 10 6 male cells was less than that of 6 x 10 5 female
cells .SCHER, AHMED, STRONG, STEINBERG, AND PALL
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FIG. 4 .
￿
Mean uptake of [311 ]TdR by spleen cellsfrom male (closed bars) or female (open bars)
CN, CN x DN, or C6 x DN mice in response to media alone (control), PHA (0.1%), Con-A
(1 .25 jig/ml), LPS (50 jug/ml), or poly I-C (250 leg/ml) . The horizontal connected lines
represent the SE obtained using three individual animals . Cultures were run in the absence of
FCS.
Skin Graft Rejection and Antibody- and Nonantibody-Mediated Cell Cytotox-
icity. Eight CN x DN males and eight females (H-21 ' 11 ) were grafted with C6
(H-2 6 ) skin and the rejection time measured . There was no significant difference
(ranksum test) between the mean rejection time for the males (11.0 days, SE f
0 .6) vs . the females (10.2 days, SE t 0.6) as shown in Table 1 .
These mice were boosted with 50 x 10 6 C6 spleen cells after graft rejection as
noted in the Materials and Methods . The ability of these sensitized CN x DN F1
male and female spleen cells to lyse EL-4 (H-2 1) tumor cells was then assayed.
There were no differences in the degree of chromium released from EL-4 tumor
cells as a result of incubation with spleen cells from sensitized CN x DN F 1
males or females (Table 11) .
However, when the EL-4 tumor cells were treated with an anti-H-2° anti-
serum, spleen cells from unsensitized CN x DN F1 females caused the release of
three times as much chromium as did unsensitized F1 male cells (Table 111) .
Spleen cells from CN males and females responded as the CN x DN F 1 males796
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￿
Uptake of [3H]TdR by spleen cells from male ("-") or female (O---O) CN x DN
mice in response to media alone (control), (a) poly I-C (50-250 )Ug/ml) or (b) LPS (2 .5-50
jug/ml) . Cultures were run in the presence of 10% FCS.
while cells from C6 x DN males and females responded as the CN x DN F,
females .
Discussion
In this paper we have studied the composition and functional characteristics of
the lymphoid system of the immune-deficient CN mice and their F, progeny .
Considerably fewer nucleated cells per spleen were noted in the immune-defi-
cient CN x DN F, males when compared to the apparently immunologically
normal F, females . In addition to a difference in the total number of nucleated
spleen cells between the F, males and females, a substantial decrease in the
percentage of B lymphocytes in the spleens of CN mice and F, males was also
seen . Thus, spleen cells from a normal strain (DN) had approximately 50%
imInunoglobulin-bearing lymphocytes whereas CN males and females and CN x
DN males had values which were similar to each other (22%, 22%, and 26%) but
approximately half that ofDN strain . Nonetheless, some individual CN mice andSCHER, AHMED, STRONG, STEINBERG, AND PAUL
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Uptake of'[ 3H]TdR by male CN x DN spleen cells exposed to media ("-") or poly
I C [250,ug/ml (0-0) 1and by female CN xDN spleen cellsexposed to media (A---6) or poly
I C [250,ug/ml (0---0) 1 for different lengths of time . Cultures were run in the presence of 10%
FCS .
CN x DN F, males had more than 35% immunoglobulin-bearing lymphocytes,
indicating that their immtnologic defect is not simply secondary to a decrease in
the number of these cells .
The level of C-dependent lysis induced by antisera directed against three
markers with predominant or exclusive expression on mouse B lymphocytes,
MBLA, a, and Ia.8 supports the data obtained with the direct staining with
labeled anti-x . It would appear, therefore, that the decrease in the number ofB
lymphocytes in the CN x DN F, males (and by inference in CN males and fe-
males) is not due to a selective absence of B lymphocytes bearing either the /c,
Ia.8, or MBLA markers, since the representation of cells bearing these markers
appears to be diminished to the same degree .
Studies of the response of spleen cells to nonspecific mitogens provide a method of
evaluating T- or B-lymphocyte cell activation (16) . There were no significant differences
in the response of spleen cells from CN x DN F, males vs . that of the females to either
Con-A orPHA . Indeed, the response to Con-A and PHA by all the animals examined was
quite comparable . Furthermore, the fraction of 0-bearing cells in the spleen cell
population of F, male and female mice was similar, as determined by an in vitro
cytotoxicity assay .798
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FIG. 7 .
￿
Uptake of [3H]TdR by increasing numbers of male (closed bars) or female (open bars)
CN xDN F, spleen cells in response to mediaalone (control), LPS (50 ug/ml), or poly I C (250
fag/ml) . The numbersunder the bars represent the number of cells per culture x 10-5 . Cultures
were run in the presence of 5% FCS .
The response of the C6 x DN F, mice andCN x DN F, female mice to the B-cell
mitogens LPS and poly I - C were equivalent and similar to that of several other
strains we have studied . However, both a very low-resting level of ['H]TdR
incorporation and a low response to LPS and poly I -C were regularly obtained
with spleen cells of CN and CN x DN F, male mice . Although the fraction of B
lymphocytes in spleen cell suspensions of CN andCN x DN F, male mice is less
than that of the other strains studied, this does not by itself explain the poor in
vitro reactivity of these cells to LPS and poly I -C . Thus, the response of8 x 10 5
F, male spleen cells to LPS or poly I-C is less than the response of 4 x 105 F,
female spleen cells whereas the number of B lymphocytes in these cultures
should be similar (Fig . 7) . Although it is likely that these results are secondary to
a qualitative abnormality in the F, male B lymphocytes, it is possible that
different ratios of adherent cells and/or T lymphocytes contribute to these
results . However, as is shown in Fig . 8, even with equivalent numbers of adherent
and T-lymphocyte-depleted spleen cells per culture, the F, male response to
LPS and poly I - C is considerably less than that of the F, female response . These
data suggest that the low response to LPS and poly I-C seen with the CN x DNSCHER, AHMED, STRONG, STEINBERG, AND PALL
FIG. 8 .
￿
Uptake of ['H]TdR by increasing numbers of male (closed bars) or female (open bars)
CN x DN F, spleen cells, depleted of adherent cellsandTlymphocytes, in response to media
alone (control), LPS (50 leg/ml), or poly I-C (250 ug/ml) . The numbers under the bars
representthenumber of cells per culture x 10 - s . Cultures were run in the presence of 5%FCS.
The response of these cells to PHA and Con-A was less than 7% of control cultures .
Skin Rejection Dayof C6 Grafts by CN x DNMalesandFemales
TABLE I
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F, male spleen cells is secondary to both a decreased absolute number of B
lymphocytes per culture and a qualitative abnormality in the ability of these B
lymphocytes to respond to these mitogens .
In order to further evaluate the functional capabilities of the T and B
lymphocytes of the CN and CN x DN F, males, we studied skin allograft
rejection, lymphocyte-mediated cytotoxicity, andADCC . Allograft rejection was
equivalent in theCN x DN F, males and females as was the ability of spleen cells
from sensitized F, males and females to kill EL-4 tumor cells . In contrast, spleen
cells of unsensitized CN x DN F, females showed an increased ability to lyse
antibody-coated EL-4 tumor cells when compared to their F, male littermates .
Thus, two immunologic functions clearly associated with T cells (17, 18) appear
normal in the immunodeficient F, males while one function, ADCC, which is
independent of T lymphocytes (19, 20) is abnormal . The decreased antibody-
dependent cytotoxicity seen with the F, male mice could be explained by either
No . of Dayofrejection
Strain Sex
animals t SEM
CN xDN M 8 11.0 f 0.57
CNxDN F 8 10 .2 0.59800
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TABLE II
Percent Chromium Released by EL-4 Tumor Cells after
Incubation with Sensitized CN x D!V !Wale or Female Cells
TABLE III
Percent Lysis of Antibody-Coated EL-4 Tumor Cells After
Incubation with Unsensitized CN,CN x DN, or C6 xDNMale
and Female Cells
lownumbers ofB lymphocytes with altered ratios of target to effector cells or to a
functional abnormality of the effector cells (17) .
Our studies have not detected any abnormality in the function ofT lymphocytes in CN
mice, whereas they provide strong evidence fora defect in certain 13-lymphocyte functions .
Although a quantitative decrease in the number Of a-bearing cells is seen in theCN mice,
as discussed above, it is unlikely that this decrease can, by itself, accountfortheabnormal
immune function seen in these animals. Thus, the proportion of immunoglobulin-bearing
cells in the spleens ofCN mice andCN x DN F1 males is approximately half normal and
the total number of spleen Blymphocytes approximately 25% of normal ; theirresponse to
the T-independent antigens SIN (1) and DNP-lys-Fico112 is undetectable under conditions
in which a response of less than 5% of normal could easily be measured . Moreover, the
immune responses ofCN x DN F, male mice to SRBC,2 DNP-keyhole limpet hemocyanin
(KLH), 2 and poly I -C complexed to methylated bovine gamma globulin (2) are all easily
measured, although diminished to variable degrees when compared to F, females . In
addition, Barthold and Janeway (personal communication) have shown that primingCN
mice with DNP-KLH generates a substantial number of primed DNP-specific precursors
of antibody-forming cells, which can be detected in transfer experiments .
These results could be explained in two general ways . On the one hand, they could be
accounted forby ageneral defect in all members of the13-lymphocyte class such that some
functions were completely lost while others were less severely affected or were normal .
Alternatively, one might postulate the existence of two (or more) independent sublines of
B lymphocytes with distinct functions . In this case, the CN mice might have a normal
representation of one subline and either absent or defective B lymphocytes of the other
subline . Although we cannot yet reach a dicision regarding these two possibilities, both the
Strain Sex
No . of
animals
Mean percent
chromium release
f SEM
CN M 3 23.0 f 1 .19
CN F 3 23.0 f 2.24
CN x DN M 8 19 .8 f 1 .03
CN x DN F 8 56.9 f 1 .54
C6 xDN M 3 56.4 t 0.67
C6 xDN F 3 58.4 t 2.33
No . of Mean percent
Strain Sex chromium release animals
t SEM
CN xDN M 5 20 .6 t 0.74
CN x DN F 5 20 .6 t 0.52SCHER, AHMED, STRONG, STEINBERG, AND PAUL
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finding that the frequency of cells bearing three distinct B markers and the observation
that many (? all) B-lymphocyte functions are at least partially impaired is more
consistent with the first possibility .
A direct influence of the X chromosome on immune function in man has been
shown by the association of IgM levels to theXchromosome (21, 22) and by the
X-linked inheritance of a number of immunodeficiency diseases . These diseases
include infantile X-linked immunodeficiency with hyper-IgM, immunodefi-
ciency with thrombocytopenia and eczema (Wiskott-Aldrich syndrome), and
X-linked severe combined immunodeficiency (23) . In all these diseases and the
X-linked immune defect seen in the CN mouse strain, the suggested cellular
defect involves B lymphocytes, supporting the conclusion that the X chromo-
some is critical to the functional development of the B-lymphocyte portion of the
immune system . There is an interesting similarity between several features of the
immune abnormalities of CN mice and of patients with the Wiskott-Aldrich
syndrome . In both of these disorders, very low concentrations ofserum IgM occur
(7, 24, 25), and the immune response to polysaccharide antigens is either very low
or absent . Lymphocytes of both the CN mice and patients with the Wiskott-
Aldrich syndrome are able to respond to 'f-lymphocyte phytomitogens (26) .
While the T-lymphocyte function in CN mice appears to be normal, there is some
evidence that it is impaired in the Wiskott-Aldrich syndrome (24, 26). However,
it has been suggested that this abnormality in T-cell function, based primarily on
the decreased skin reactivity seen in these patients, is a secondary rather than a
primary phenomenon (24) . Further studies of theCN mouse strain may provide a
model to study both B-lymphocyte differentiation and activation and to aid in
the evaluation of the cellular deficiency in at least some forms ofhuman immune
deficiency diseases .
Summary
A study of the composition and functional properties of spleen cells from the
immune deficient CBA/HN mice and their F, progeny is reported . While
abnormalities were seen in both the numbers and function of thymus-independ-
ent (B) lymphocytes, all studies involving thymus-dependent (T) lymphocytes
were normal . The X-linked nature of the immune defect in these mice was
therefore attributed to abnormal or absentB lymphocytes. The possible nature of
this defect and the similarity of the immune defect in these mice to certain
human X-linked immunodeficiency diseases are discussed .
We would like to acknowledge the excellent technical support of Miss A. Berning and HM1 K.
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